Sumitomo Chemical Company, Limited (TYO:4005)
Japan · Delayed Price · Currency is JPY 538.60
-14.20 (-2.57%)
Jul 24, 2026, 3:30 PM JST
Sumitomo Chemical Company Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,328,515 | 2,328,515 | 2,606,281 | 2,446,893 | 2,895,283 | 2,765,321 |
Revenue Growth | -10.66% | -10.66% | 6.51% | -15.49% | 4.70% | 20.92% |
Gross Profit Gross Profit Growth | 668,268 | 668,268 | 725,476 | 499,695 | 820,926 | 873,863 |
Operating Income Operating Income Growth | 106,565 | 106,565 | 110,185 | -393,918 | -57,327 | 181,567 |
Net Income Net Income Growth | 60,947 | 60,947 | 38,591 | -311,838 | 6,987 | 162,130 |
Earnings Per Share EPS Growth | 37.15 | 37.15 | 23.58 | -190.69 | 4.27 | 99.16 |
EPS Growth | 57.55% | 57.55% | - | - | -95.69% | 252.13% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Agro & Life Solutions Agro & Life Solutions Growth | 520,350 | 520,350 | 541,335 | 552,010 | 604,044 | 480,838 |
Others Others Growth | 94,764 | 94,764 | 165,085 | 153,113 | 172,748 | 129,604 |
Ict & Mobility Solutions Ict & Mobility Solutions Growth | 575,130 | 575,130 | 610,253 | - | - | - |
Essential & Green Materials Essential & Green Materials Growth | 683,376 | 683,376 | 903,903 | 779,439 | 858,610 | 847,932 |
Unallocated Adjustments Unallocated Adjustments Growth | -70,812 | -70,812 | -85,358 | -112,419 | -116,624 | -87,711 |
Sumitomo Pharma Sumitomo Pharma Growth | 453,294 | 453,294 | 398,530 | 342,739 | 584,888 | 591,724 |
Advanced Medical Solutions Advanced Medical Solutions Growth | 72,413 | 72,413 | 72,533 | - | - | - |
Total Total Growth | 2,328,515 | 2,328,515 | 2,606,281 | 2,446,893 | 2,895,283 | 2,765,321 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 208,589 | 208,589 | 209,838 | 217,449 | 305,844 | 365,429 |
Total Debt Total Debt Growth | 1,151,455 | 1,151,455 | 1,286,128 | 1,563,486 | 1,461,366 | 1,350,470 |
Net Cash (Debt) Net Cash Growth | -942,866 | -942,866 | -1,076,290 | -1,346,037 | -1,155,522 | -985,041 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -574.66 | -574.66 | -657.67 | -823.09 | -706.62 | -602.48 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 234,759 | 234,759 | 233,027 | -51,317 | 111,621 | 171,715 |
Capital Expenditures CapEx Growth | -121,566 | -121,566 | -130,465 | -152,873 | -143,581 | -107,467 |
Free Cash Flow Free Cash Flow Growth | 113,193 | 113,193 | 102,562 | -204,190 | -31,960 | 64,248 |
Free Cash Flow Growth | 10.37% | 10.37% | - | - | - | -74.67% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 28.70% | 28.70% | 27.84% | 20.42% | 28.35% | 31.60% |
Operating Margin | 4.58% | 4.58% | 4.23% | -16.10% | -1.98% | 6.57% |
Pretax Margin | 4.98% | 4.98% | 2.23% | -18.91% | 0.01% | 9.08% |
Profit Margin | 2.62% | 2.62% | 1.48% | -12.74% | 0.24% | 5.86% |
FCF Margin | 4.86% | 4.86% | 3.94% | -8.34% | -1.10% | 2.32% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 16.000 | 13.500 | 9.000 | 9.000 | 18.000 | 24.000 |
Dividend Per Share Growth | 29.17% | 50.00% | 0% | -50.00% | -25.00% | 60.00% |
Dividend Yield | 2.97% | 2.70% | 2.56% | 2.80% | 4.35% | 4.77% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.50 | 13.42 | 15.33 | - | 104.16 | 5.67 |
Forward PE | 10.72 | 43.61 | 8.95 | 137.21 | 9.51 | 6.66 |
P/FCF Ratio | 7.86 | 7.23 | 5.77 | - | - | 14.30 |
PS Ratio | 0.38 | 0.35 | 0.23 | 0.23 | 0.25 | 0.33 |